ATLASATLAS fair value
ATLAS has no fair value for this stock today.
EMEIS (EMEIS.PA)
EMEIS stock price today, ATLAS forecast and fair value
Healthcare · Medical Care Facilities · Euronext Paris · France
€9.77▲ +0.21%
Prices as of Oct 26, 2026 · EUR
Chance of rising in 1 month
49%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on EMEIS in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On EMEIS
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives EMEIS a 49% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between €8.99 and €10.55; in 9 out of 10, between €7.81 and €12.15. Estimated annual volatility is 32%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- €1.6B
- Market cap (USD)
- $1.8B
- 52-week high
- €16.01
- 52-week low
- €9.34
- Revenue (12 months)
- €6.0B
- Gross margin
- 14.6%
- Operating margin
- 6.2%
- Net margin
- -3.4%
- Beta
- 0.67
What this means
ATLAS does not publish a fair value for EMEIS.PA right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks EMEIS.PA has traded between €9.34 and €16.01. Today it is 39.0% below that high and 5% above its low.
Its beta is 0.67: it tends to move less than the market.
About the company
emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, retirement homes, and psychiatric hospitals.
Want to see everything about EMEIS?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does EMEIS do?
emeis Société anonyme operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, retirement homes, and psychiatric hospitals.
What is the chance EMEIS.PA goes up next month?
49%: close to a coin flip. In half of the simulated outcomes, EMEIS.PA ends the month between €8.99 and €10.55.
How big is EMEIS and what is its P/E ratio?
EMEIS's market capitalization is €1.6B. We do not show a P/E because it has no positive earnings to base one on.
How volatile is EMEIS.PA?
ATLAS estimates annual volatility at 32%. In a typical month, half of the outcomes end between €8.99 and €10.55.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer